New CEO to lead rollout of breakthrough cathode active material (CAM) encapsulation technology as Volexion closes strategic ...

Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in ...

Allurion Technologies said patients treated with its weight-loss program in a clinical study maintained higher muscle mass and had a bigger decrease in fat percentage. The developer of obesity ...

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in France next month following the successful resumption of product shipments.

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

Allurion Technologies, Inc. (ALUR) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of a loss of $1.53 per share. This compares to earnings of $2.75 per ...

Allurion Technologies Inc. (ALUR) reported a notable decline in revenue for Q1 2025, with figures decreasing to $5.6 million from $9.4 million in the same period last year. Despite the revenue ...